{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:12:09Z","timestamp":1768479129270,"version":"3.49.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T00:00:00Z","timestamp":1611100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007343","name":"Shire","doi-asserted-by":"publisher","award":["IIR-ESP-001305"],"award-info":[{"award-number":["IIR-ESP-001305"]}],"id":[{"id":"10.13039\/100007343","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/01941"],"award-info":[{"award-number":["PI17\/01941"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s12265-020-10097-2","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T17:02:41Z","timestamp":1611162161000},"page":"948-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Screening of Fabry Disease in Patients with Chest Pain Without Obstructive Coronary Artery Disease"],"prefix":"10.1007","volume":"14","author":[{"given":"Aitor","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Diez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Palomino-Doza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Eugenia","family":"Fuentes-Ca\u00f1amero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Mogoll\u00f3n Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Casanova Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Ruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coloma","family":"Tir\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Climent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-2257","authenticated-orcid":false,"given":"Pablo","family":"Garcia-Pavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,20]]},"reference":[{"issue":"4","key":"10097_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz, A., Germain, D. P., Desnick, R. J., Politei, J., Mauer, M., Burlina, A., et al. (2018). Fabry disease revisited: management and treatment recommendations for adult patients. Molecular Genetics and Metabolism, 123(4), 416\u2013427.","journal-title":"Molecular Genetics and Metabolism"},{"key":"10097_CR2","doi-asserted-by":"publisher","first-page":"e12914","DOI":"10.1111\/ijcp.12914","volume":"71","author":"R Reisin","year":"2017","unstructured":"Reisin, R., Perrin, A., & Garc\u00eda-Pav\u00eda, P. (2017). Time delays in the diagnosis and treatment of Fabry disease. International Journal of Clinical Practice, 71, e12914.","journal-title":"International Journal of Clinical Practice"},{"issue":"1","key":"10097_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13023-019-1140-3","volume":"14","author":"\u00c1 L\u00f3pez-Sainz","year":"2019","unstructured":"L\u00f3pez-Sainz, \u00c1., Climent, V., Ripoll-Vera, T., Espinosa, M. A., Barriales-Villa, R., Navarro, M., et al. (2019). Negative screening of Fabry disease in patients with conduction disorders requiring a pacemaker. Orphanet Journal of Rare Diseases, 14(1), 170.","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"12","key":"10097_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/eurjhf\/hft104","volume":"15","author":"B Tomberli","year":"2013","unstructured":"Tomberli, B., Cecchi, F., Sciagr\u00e0, R., Berti, V., Lisi, F., Torricelli, F., et al. (2013). Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. European Journal of Heart Failure, 15(12), 1363\u20131373.","journal-title":"European Journal of Heart Failure"},{"issue":"2","key":"10097_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1253\/circj.CJ-18-0734","volume":"83","author":"Y Kitani","year":"2019","unstructured":"Kitani, Y., Nakagawa, N., Sakamoto, N., Takeuchi, T., Takahashi, F., Momosaki, K., et al. (2019). Unexpectedly high prevalence of coronary spastic angina in patients with Anderson-Fabry Disease. Circulation Journal, 83(2), 481\u2013484.","journal-title":"Circulation Journal"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10097-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10097-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T16:17:16Z","timestamp":1636388236000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10097-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,20]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10097"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10097-2","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,20]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"VC reports consulting fees and research funding from Sanofi-Genzyme, Takeda, and Amicus. PGP reports consulting fees and research funding to his institution from Sanofi-Genzyme and Takeda. Other authors have no conflict of interest relevant to this work to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}